
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
Thetis is a drug development company that is advancing TP101, a novel, first-line therapy for type 2 diabetes.
Headlines from Mass High Tech about THETIS PHARMACEUTICALS LLC
Print this Listing
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
| Year Established | 2011 |
| Ownership Type | Private |
| Venture Funding | Subscriber access only |
| Frank Sciavolino | CSO/President | email available to subscribers | ||
| Gary Mathias | CFO | email available to subscribers |
* Downloads will not contain Personnel E-mail addresses
| Focus | Biotechnology - Pharmaceutical |
| Location | Southport, CT |
| Website | http://www.thetispharma.com |
| Revenue | Subscriber access only |
| Address |
167 Old Post Rd 2nd Floor Southport, CT, 06890 |
| Phone | 203-256-7753 |
| Subscriber access only | |
| Website | www.thetispharma.com |